Hui Jing1, Wen Cheng2, Zi-Yao Li3, Liu Ying2, Qiu-Cheng Wang2, Tong Wu3, Jia-Wei Tian4. 1. Department of Ultrasound, Second Affiliated Hospital of Harbin Medical University, Harbin, China. Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China. 2. Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China. 3. Department of Ultrasound, Second Affiliated Hospital of Harbin Medical University, Harbin, China. 4. Department of Ultrasound, Second Affiliated Hospital of Harbin Medical University, Harbin, China jwtian2004@163.com.
Abstract
OBJECTIVES: Neoadjuvant chemotherapy plays an important role in comprehensive therapy for breast cancer, but response prediction is imperfect. Shear wave elastography (SWE) is a novel technique that can quantitatively evaluate tissue stiffness. In this study, we sought to investigate the application value of SWE for early prediction of the response to neoadjuvant chemotherapy in patients with breast cancer. METHODS: We prospectively evaluated tumor stiffness in 62 patients with breast cancer using SWE, which was performed at baseline and after the second cycle of neoadjuvant chemotherapy. After chemotherapy, all of the patients underwent surgery. We investigated the correlations between the relative changes in tumor stiffness (Δ stiffness) after 2 cycles of chemotherapy and the pathologic response to the therapy. RESULTS: Compared with baseline values, tumor stiffness after 2 cycles of neoadjuvant chemotherapy was significantly decreased in responders (P < .001) but not in nonresponders (P = .172). The Δstiffness was significantly higher in responders (-42.194%) than in nonresponders (-23.593%; P = .001). As determined at either the baseline or after the second cycle of chemotherapy, tumor stiffness was significantly lower in responders than in nonresponders (P = .033 and .009, respectively). The Δ stiffness threshold for distinguishing between responders and nonresponders was -36.1% (72.92% sensitivity and 85.71% specificity). Furthermore, correlating Δ stiffness with clinical and pathologic characteristics, we found that estrogen and progesterone receptor expression showed statistically significant correlations with Δ stiffness (estrogen receptor, P = .008; progesterone receptor, P = .023). CONCLUSIONS: Early evaluation of relative changes in tumor stiffness using SWE could effectively predict the response to neoadjuvant chemotherapy in patients with breast cancer and might indicate better therapeutic strategies on a timelier basis.
OBJECTIVES: Neoadjuvant chemotherapy plays an important role in comprehensive therapy for breast cancer, but response prediction is imperfect. Shear wave elastography (SWE) is a novel technique that can quantitatively evaluate tissue stiffness. In this study, we sought to investigate the application value of SWE for early prediction of the response to neoadjuvant chemotherapy in patients with breast cancer. METHODS: We prospectively evaluated tumor stiffness in 62 patients with breast cancer using SWE, which was performed at baseline and after the second cycle of neoadjuvant chemotherapy. After chemotherapy, all of the patients underwent surgery. We investigated the correlations between the relative changes in tumor stiffness (Δ stiffness) after 2 cycles of chemotherapy and the pathologic response to the therapy. RESULTS: Compared with baseline values, tumor stiffness after 2 cycles of neoadjuvant chemotherapy was significantly decreased in responders (P < .001) but not in nonresponders (P = .172). The Δstiffness was significantly higher in responders (-42.194%) than in nonresponders (-23.593%; P = .001). As determined at either the baseline or after the second cycle of chemotherapy, tumor stiffness was significantly lower in responders than in nonresponders (P = .033 and .009, respectively). The Δ stiffness threshold for distinguishing between responders and nonresponders was -36.1% (72.92% sensitivity and 85.71% specificity). Furthermore, correlating Δ stiffness with clinical and pathologic characteristics, we found that estrogen and progesterone receptor expression showed statistically significant correlations with Δ stiffness (estrogen receptor, P = .008; progesterone receptor, P = .023). CONCLUSIONS: Early evaluation of relative changes in tumor stiffness using SWE could effectively predict the response to neoadjuvant chemotherapy in patients with breast cancer and might indicate better therapeutic strategies on a timelier basis.
Entities:
Keywords:
breast cancer; breast ultrasound; neoadjuvant chemotherapy; pathologic response; shear wave elastography; tumor stiffness
Authors: Jin You Kim; Jin Joo Kim; Lee Hwangbo; Hie Bum Suh; Ji Won Lee; Nam Kyung Lee; Ki Seok Choo; Suk Kim Journal: Br J Radiol Date: 2021-10-05 Impact factor: 3.039
Authors: Patrizia Romani; Nunzia Nirchio; Mattia Arboit; Vito Barbieri; Anna Tosi; Federica Michielin; Soichi Shibuya; Thomas Benoist; Danchen Wu; Charles Colin Thomas Hindmarch; Monica Giomo; Anna Urciuolo; Flavia Giamogante; Antonella Roveri; Probir Chakravarty; Marco Montagner; Tito Calì; Nicola Elvassore; Stephen L Archer; Paolo De Coppi; Antonio Rosato; Graziano Martello; Sirio Dupont Journal: Nat Cell Biol Date: 2022-02-14 Impact factor: 28.213
Authors: Paul E Oberstein; Niloufar Saharkhiz; Thomas Payen; Carmine F Palermo; Stephen A Sastra; Yang Han; Alireza Nabavizadeh; Irina R Sagalovskiy; Barbara Orelli; Vilma Rosario; Deborah Desrouilleres; Helen Remotti; Michael D Kluger; Beth A Schrope; John A Chabot; Alina C Iuga; Elisa E Konofagou; Kenneth P Olive Journal: Clin Cancer Res Date: 2019-12-12 Impact factor: 12.531
Authors: Andy Evans; Yee Ting Sim; Celine Pourreyron; Alastair Thompson; Lee Jordan; Dawn Fleming; Colin Purdie; Jane Macaskill; Sarah Vinnicombe; Paul Pharoah Journal: Breast Cancer Res Treat Date: 2018-06-01 Impact factor: 4.872
Authors: Juanjuan Gu; Eric C Polley; Max Denis; Jodi M Carter; Sandhya Pruthi; Adriana V Gregory; Judy C Boughey; Robert T Fazzio; Mostafa Fatemi; Azra Alizad Journal: Breast Cancer Res Date: 2021-04-29 Impact factor: 8.408